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The new generation of whole genome sequencing platforms offers great possibilities and challenges for dissecting
the genetic basis of complex traits. With a very high number of sequence variants, a naïve multiple hypothesis
threshold correction hinders the identification of reliable associations by the overreduction of statistical power. In
this report, we examine 2 alternative approaches to improve the statistical power of a whole genome association
study to detect reliable genetic associations. The approaches were tested using the Genetic Analysis Workshop 19
(GAW19) whole genome sequencing data. The first tested method estimates the real number of effective
independent tests actually being performed in whole genome association project by the use of an extreme value
distribution and a set of phenotype simulations. Given the familiar nature of the GAW19 data and the finite number
of pedigree founders in the sample, the number of correlations between genotypes is greater than in a set of
unrelated samples. Using our procedure, we estimate that the effective number represents only 15 % of the total
number of independent tests performed. However, even using this corrected significance threshold, no genome-wide
significant association could be detected for systolic and diastolic blood pressure traits.
The second approach implements a biological relevance-driven hypothesis tested by exploiting prior computational
predictions on the effect of nonsynonymous genetic variants detected in a whole genome sequencing association
study. This guided testing approach was able to identify 2 promising single-nucleotide polymorphisms (SNPs), 1 for
each trait, targeting biologically relevant genes that could help shed light on the genesis of the human hypertension.
The first gene, PFH14, associated with systolic blood pressure, interacts directly with genes involved in calcium-channel
formation and the second gene, MAP4, encodes a microtubule-associated protein and had already been detected by
previous genome-wide association study experiments conducted in an Asian population. Our results highlight the
necessity of the development of alternative approached to improve the efficiency on the detection of reasonable
candidate associations in whole genome sequencing studies.* Correspondence: Marcio.Almeida@utrgv.edu
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The new generation of sequencing platforms has dra-
matically altered the genetics field by allowing a cost-
effective approach to completely explore the information
stored in a genome of interest. Large genetic and epide-
miologic projects are beginning to utilize whole genome
sequencing (WGS) to identify genetic variants (especially
novel rare variants) that could explain the missing herit-
ability paradox [1]. The paradox had been formulated
during the genome wide association (GWA) era; those
platforms are based on the CDCV (common disease
common variant) premise. GWA studies have shown
modest success for the identification of causal genetic
variants associated with common diseases with high so-
cial impact, such as diabetes, hypertension, and cancer.
The WGS approach tries to fill this large information
gap by capturing all available genetic variations, includ-
ing the novel, rare, and private variants that only appear
in a specific family. Despite the substantial promise and
potential, many statistical and analytical challenges still
need to be surpassed for the efficient analysis of WGS
data for the identification of causal genes.
The astronomical number of independent hypotheses
tested on a WGS study, above 10 million tests, incurs
substantial costs in terms of statistical power. Clearly,
only a small subset of sequence variants is molecularly
functional and even fewer are phenotypically functional
with regard to a focal trait of interest. The assessment of
the LD (linkage disequilibrium) between single-nucleotide
polymorphisms (SNPs) in a WGS project is challenging
because of the immense number of rare variants identi-
fied, the potential for cross-chromosome gametic disequi-
librium, and, consequently, the immense number of
possible pairwise correlations. A reduction in the number
of relevant hypotheses tested is possible by incorporating
prior knowledge of functional potential or localization of
genetic variants on a target gene of interest. Many differ-
ent computational approaches have been proposed for a
fast and accurate prediction of the functional outcome of
nonsynonymous variants. The prior selection of variants
with a common functional classification of interest can
directly reduce the number of tests carried out. It leads to
a biologically informed hypothesis-driven exploration that
should yield simpler interpretation of observed results.
The addition of biologically relevant databases such as
GO (Gene Ontology) or KEGG (Kyoto Encyclopedia of
Genes and Genomes) greatly improve the interpretation
of results gathered in a WGS association project [1].
In this report, we applied 2 distinct methods to in-
crease the statistical power of our analysis by reducing
the hypothesis state space of the association analysis per-
formed. The first estimates the number of effective inde-
pendent tests performed in WGS (or any subset of the
genome) by fitting the observed extreme p values to abeta distribution following the method proposed by
Dudbridge and Gusnanto [2]. The method is based on
the extreme value distribution theory and estimates the
effective number of tests parameter from a beta distribu-
tion β(1,ne) where ne is the effective number of tests [3].
The estimate of ne is the parameter β in the beta distri-
bution and the best parameter is defined by a maximum
likelihood approach. This method empirically controls
for the redundancy that is inherent in correlated hypoth-
eses, such as the testing of sequence variants that are in
linkage/gametic disequilibrium without explicitly requir-
ing estimation of the pairwise correlations. The second
general tested approach was the reduction of the hy-
pothesis state space using computational mapping to
identify molecularly functional nonsynonymous variants.
Using this subset of variants, 2 new significance thresh-
olds were defined: the Bonferroni multiple hypothesis
correction, and the second a LD corrected multiple hy-
pothesis correction using the data generated for the first
approach. Both methods were tested using the set of real
systolic and diastolic phenotypes provided for Genetic
Analysis Workshop 19 (GAW19) and 2 very promising
associations were identified. Those nonsynonymous vari-
ants have the potential to disrupt the proteins coded by
the genes PFH14 and MAP4. Both genes are promising
candidates and support our method to improve the stat-
istical power of a highly dimensional WGS association
project.
Methods
Data acquisition and quality filtering
All our analyses were performed using the GAW19
WGS family data set. A group of 6538591 SNPs with
more than 5 copies of the minor allele counts (MACs)
had been filtered from the initial set of 8,348,674 genetic
variants. This minimum number of MACs is required to
achieve approximate asymptotic test statistic expecta-
tions under the null hypothesis and was chosen based
on a previously performed computer simulation. The
large set of variants filtered was subdivided in groups of
500 SNPs to allow an efficient process parallelization
and the files generated organized locally in our server.
Creation of an extreme value distribution and definition
of the number of effective independent tests
We simulated 1000 quantitative phenotypes under the
null hypothesis of no genetic effects (h2 = 0). For each
simulated phenotype, we performed full WGS-based
association analyses for all single-nucleotide variants
(SNVs) filtered in the last item. All association analyses
were performed using the linear mixed model imple-
mented in SOLAR (Sequential Oligogenic Linkage Ana-
lysis Routines), allowing for residual nonindependence
between relatives [4]. The observed association results
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sociation (p value) extracted. The distribution of 1000
extreme p values was fit to a theoretical beta distribution
and maximum likelihood estimation was used to estimate
the β parameter that is directly related to the effective
number of tests. This corrected number of effective tests
is used to define a new multiple hypothesis Bonferroni
correction in the form of target α ¼ 0:05=nef where nef is
the number of effective tests defined by the β parameter.
Definition of nonsynonymous variants
The genomic localization information (chromosome and
position), the corresponding reference genome, and the
alternative allele of each variant were jointly used as an
input for the ANNOVAR (Annotate Variation) annotation
tool [5]. All annotation was done using the corresponding
hg19 gene annotation table and the prediction functional
outcome of the nonsynonymous variants was determined
using PolyPhen [6] and SIFT (sorting intolerant from
tolerant) [7]. A set of 28,292 nonsynonymous SNPs was
identified in the WGS data provided.
Association analysis using the real phenotypic data
The measurements of systolic and diastolic blood pres-
sure (SBP_1 and DBP_1) were normalized using an in-
verse Gaussian procedure. In all analyses, we included
the covariate effects of smoking status, blood pressure
medication usage, sex, age, age2, sex*age, sex*age2, and 3
principal components extracted from the genotypic dos-
age information (using unrelateds only) to account for
latent population structure.
Results
Estimation of the effective number of tests
The GAW19 WGS was obtained and initially we filtered
6,538,591 SNPs with 5 or more copies of the alternative
allele. A set of 1000 simulated phenotypes were gener-
ated under a null hypothesis of no genetic association
with no heritability estimate. The filtered SNVs had their
association with the simulated phenotypes determined
using a linear mixed-model approach implemented in
SOLAR. For each phenotypic simulation, the set of p values
were sorted and the most extreme association was de-
termined. Using the approach proposed by Dudbridge
and Gusnanto in 2008 [2], we estimated the effective
number of tests that maximized the fit of the set of
extreme p value to a theoretical beta distribution. Based
on this procedure, we estimated that there are only
947,109 effectively independent tests performed, corre-
sponding to an astounding reduction of 85 % in the
number of performed tests. The relatively small number
of founder individuals strongly influences this reduc-
tion. This new estimate was employed to calculate a
statistically appropriate multiple hypothesis significancethreshold of 5.27 × e−8. Given the large number of
complete WGS association analyses (n = 1000) per-
formed, we also checked if the effective number of tests
was consistent across the totality of the empirical null
distribution. The fit appeared to be excellent suggesting
that a theoretical beta distribution recapitulate the most
important parameters features from the null distribu-
tion of extreme p values.
Using the provided real SBP and DBP data, we tested
the association of each of the 6.5 M SNVs using smoking
status, blood pressure medication usage, sex, age, age2,
sex*age, sex*age2, and 3 principal components as covari-
ates. All associations were obtained using the linear
mixed model implemented in SOLAR and interpreted
using our previous simulation results (Fig. 1). The set of
SNVs was tested for association using the new corrected
multiple hypothesis significance threshold (red line)
compared to the naïve Bonferroni correction, taking into
account all SNVs in the experiment (black line). The
association results for SBP are shown in Fig. 1a; the plot
clearly shows that no association was identified for this
trait. The top association observed for SBP was detected
in the SNP rs218982 (p value <6.81 e−07) located in a
nonconserved region 10 kb upstream of the gene PHF14
in chromosome 7. The association results for DBP are
shown in the Fig. 1c; and such as SBP, no clear associ-
ation would be detected (Fig. 1d). The top association
observed for DBP was detected in the SNP rs28429841
(p value <4.70 e−07), a rare variant with only 16 copies of
the minor allele. That genetic variant is located in an
intronic sequence of the gene MAP4 in chromosome 3.
Hypothesis reduction using prior biological information
The results in the last item explain the necessity of alter-
native procedures to further reduce the search space and
improve the statistical power of a WGS association ex-
periment. To accomplish such task, we reduce the
search space by mapping each SNV in the latest human
genome assembly (hg19) and identify a set of 28,292
nonsynonymous SNVS. This specific type of genetic
variation is the cream of the crop in an association study
because it directly pinpoints a candidate gene, simplify-
ing the interpretation of the results. As expected, this
reduced hypothesis test state space requires less statis-
tical evidence for association. The Bonferroni multiple hy-
pothesis correction in this set requires a target alpha for a
genome-wide significance of only 1.76 × e−6, an approxi-
mately 100 times higher statistical threshold than the one
required for a whole genome association. The nonsynon-
ymous SNVs were a subset from the simulation results
and the p values were fitted into an extreme value distri-
bution, leading to the estimate of 13,399 independent
tests. This reduced set of independent tests required a
corrected new multiple hypotheses significance threshold
Fig. 1 Manhattan plot representations. a WGS association analysis of the trait SBP; b nonsynonymous variants and their association with SBP;
c WGS association analysis of the trait DBP; d nonsynonymous variants and their association with DBP. The black lines represent the Bonferroni
multiple hypothesis threshold and the red lines the adjusted new corrected multiple hypothesis
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ation results for SBP and DBP. Two SNVs, 1 for each trait,
would be considered associated (see Fig. 1b and d). Inter-
estingly, the genes carrying the most significant associated
SNVs detected in the hypothesis-free WGS analysis, using
all identified, SNVs were also detected in the nonsynon-
ymous analysis.
The first SNV, rs218966, leads to a missense mutation
(K115R) located in the second exon of the gene PHF14
on chromosome 7 and shows a significant association
with SBP (p value <1.13 × e−6). This gene encodes a zinc
finger class transcription factor that controls the expres-
sion of the PCBD2 gene that had been involved in the
calcium channels formation [8]. Calcium channels are
considered classical candidates to explain the development
of pulmonary arterial hypertension and calcium-channel
blockers are prescribed for treatment [9]. This variant was
predicted to be benign by PolyPhen algorithm [6]. The
second nonsynonymous SNV (rs9836027) identified israre, is a missense mutation (E118K) that affects the gene
MAP4, and is strongly associated with DBP (p value <5.1e
−7). The SNV is located in an alternative use exon of the
MAP4 gene and the genetic variant is present in 2 of the 8
known gene isoforms. The MAP4 gene encodes a
microtubule-associated protein that is central to the con-
trol of cellular cycle. SNVs in this gene had already been
associated with pulse pressure and mean arterial pressure
in Asian individuals [10]. The association of this specific
variant with DBP is novel and the functional impact of this
nonsynonymous variant was predicted to be tolerable by
PolyPhen, but deleterious using SIFT [7]. This discordance
outlines the necessity of a further in vivo experimental
validation to understand exactly the role of these genetic
associations in a larger human hypertension paradigm.
Discussion and conclusions
WGS platforms are becoming more cost effective and
their application in large human pedigree studies, like San
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rare variants that are population, or even family, specific.
The number of genetic variants identified in such projects
is astronomical, and the required multiple hypothesis
threshold correction reduces the statistical power. In this
report, we used the WGS data provided by the GAW19
organization to test 2 alternative approaches to improve
the statistical power of a WGS association study and favor
the detection of reliable candidate genes. The first
approach efficiently eliminates the redundancy of link-
age/gametic disequilibrium among SNVs by the use of
the extreme value theory. The estimation of LD in a
dense panel of genetic marker is challenging due to a
result of the required n2/2 computational complexity.
The approximation of the extreme value distribution to
a theoretical beta distribution was proposed by Šidák in
1967 and their applicability in association studies was
proposed by Dudbridge and Gusnanto in 2008 [2]. The
number of effective independent tests carried was
reduced from 6.5 M to less than 1 M (an 85 % reduc-
tion), resulting in the statistical power improving by the
same proportion. The Bonferroni correction and the
newly proposed corrected multiple hypothesis correc-
tion thresholds were applied to the association results of
systolic and diastolic blood pressure (see Fig. 1a and c).
No clear associations would be detected for both traits.
The second approach uses prior biological prediction to
formulate an overarching hypothesis that is biased to-
ward the identification of SNVs with functional poten-
tial impact. The nonsynonymous variants offer a
targeted hypothesis toward the identification of candi-
date genes by simplifying the results annotation. We
identified a set of 28,292 nonsynonymous SNVs in the
GAW19 data. The dependence between nonsynon-
ymous SNVs was eliminated by the use of the extreme
value theory and a new multiple hypothesis corrected
significance threshold of 3.73 × e−6 was defined. This
procedure led to the identification of 2 missense SNVs
significantly correlated with human blood pressure. The
gene MAP4 was previously associated with blood pres-
sure alterations in Asian populations and the identified
nonsynonymous SNV requires further functional valid-
ation. Our analyses highlight the necessity of the devel-
opment of alternative methods favoring the detection of
reasonable candidate genes in a WGS paradigm.Acknowledgements
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